09:01 GMT, Wednesday, 2 April 2008 10:01 UK
Sickness drug extension approved
A Borders pharmaceutical firm has been cleared to market an anti-sickness drug in the UK and Germany.
Galashiels-based ProStrakan has estimated the total value of the German market could be more than £10m.
It already sells the drug - designed to treat post-operative nausea - in eight other European countries.
Sales of xomolix totalled £4.2m in 2007 and the company believes there is a "substantial level" of demand for the product in the new nations.
A total of eight countries are involved in the new marketing clearance.
E-mail this to a friend
Related to this story:
Drugs firm seeks US breakthrough
(22 Oct 07 |
South of Scotland
)
'Male menopause' gel is launched
(12 Jun 07 |
Health
)
Borders firm nets £74m drug deal
(28 Sep 06 |
South of Scotland
)
East European deal for drugs firm
(27 Jul 06 |
South of Scotland
)
Scots firm announces huge US deal
(14 Jul 06 |
South of Scotland
)
RELATED INTERNET LINKS
ProStrakan
The BBC is not responsible for the content of external internet sites
News Front Page
|
Africa
|
Americas
|
Asia-Pacific
|
Europe
|
Middle East
|
South Asia
|
UK
|
Business
|
Health
|
Science & Environment
|
Technology
|
Entertainment
|
Also in the news
|
Have Your Say
|
UK Contents:
England
|
Northern Ireland
|
Scotland
|
Wales
|
UK Politics
|
Education
|
Magazine
NewsWatch | Notes | Contact us | About BBC News | Profiles | History
~RS~q~RS~~RS~z~RS~59~RS~)